Skip to content

A Pilot study to evaluate the safety and efficacy of Gunmakudori Mezhugu in the management of Polycystic ovarian syndrome (PCOS).

A pilot study to evaluate the safety and efficacy of Gunmakudori Mezhugu (GKM) in the management of Garpa vayu (PCOS) in the women of reproductive age.

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/03/041489
Enrollment
34
Registered
2022-03-30
Start date
Unknown
Completion date
Unknown
Last updated
2023-12-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E282- Polycystic ovarian syndrome

Interventions

Intervention1: Gunmakudori Mezhugu: Gunmakudori Mezhugu – 1gm with hot water twice daily after food for 90 days (3 courses of 30 days with drug holiday of 5 days between each course). Ref: Siddha vait

Sponsors

Central Council for Research in Siddha
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Age limit 18 years to 45 years. 2.PCOS women diagnosed by Rotterdam criteria. 3.Presence with Oligomenorrhea or Amenorrhea after negative screening pregnancy test. 4.Hyperandrogenism clinically Hirsutism, Biochemically elevated serum testosterone concentrations. 5.Polycystic ovaries.

Exclusion criteria

Exclusion criteria: 1.Age younger than 18 or older than 45 2.Hyperandrogenism due to other reasons including hyperprolactinemia, thyroid diseases, congenital adrenal hyperplasia, Cushing syndrome etc. 3.Subjects with metabolic, endocrinal disorders and psychiatric illnesses. 4.Not associated with any organic reproductive system abnormalities. 5.Current or previous (within the last 3 months) use of oral contraceptives. 6.Pregnant or suspected to be pregnant.

Design outcomes

Primary

MeasureTime frame
To assess the safety of trial drug by evaluating the objective parameters of LFT and RFTTimepoint: 90 days

Secondary

MeasureTime frame
Changes in reproductive hormones level and Changes in size and number of ovarian follicle.Timepoint: 90 days

Countries

India

Contacts

Public ContactDr A Lavanya

Siddha Regional Research Institute, Central Council for Research in Siddha (Ministry of AYUSH, GOI.)

drlavi85@gmail.com9042606902

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026